BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28686474)

  • 1. Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents.
    Sallee F; Kohegyi E; Zhao J; McQuade R; Cox K; Sanchez R; van Beek A; Nyilas M; Carson W; Kurlan R
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):771-781. PubMed ID: 28686474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
    Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
    J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and tolerability of aripiprazole in children and adolescents with Tourette's disorder: a pilot study in China.
    Cui YH; Zheng Y; Yang YP; Liu J; Li J
    J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):291-8. PubMed ID: 20807067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.
    Lyon GJ; Samar S; Jummani R; Hirsch S; Spirgel A; Goldman R; Coffey BJ
    J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):623-33. PubMed ID: 20035580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
    Coffey B; Jankovic J; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander JK; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2129397. PubMed ID: 34661664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette's syndrome: a systematic review and network meta-analysis.
    Farhat LC; Behling E; Landeros-Weisenberger A; Levine JLS; Macul Ferreira de Barros P; Wang Z; Bloch MH
    Lancet Child Adolesc Health; 2023 Feb; 7(2):112-126. PubMed ID: 36528030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
    Jankovic J; Coffey B; Claassen DO; Jimenez-Shahed J; Gertz BJ; Garofalo EA; Stamler DA; Wieman M; Savola JM; Gordon MF; Alexander J; Barkay H; Harary E
    JAMA Netw Open; 2021 Oct; 4(10):e2128204. PubMed ID: 34609495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study.
    Toren P; Weizman A; Ratner S; Cohen D; Laor N
    J Clin Psychiatry; 2005 Apr; 66(4):499-503. PubMed ID: 15816793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
    Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Meta-Analysis.
    Liu Y; Ni H; Wang C; Li L; Cheng Z; Weng Z
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):436-41. PubMed ID: 26914764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Yi-Gan-san on the psychiatric behavior of children and adolescents with Tourette's Syndrome: A randomized, double-blind, controlled preliminary study.
    Huang CH; Liao WL; Lee DY; Chou IC; Wang MY; Hsieh CL
    J Ethnopharmacol; 2022 May; 290():115098. PubMed ID: 35182665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ; Lane R; Nuamah I; Gopal S; Hough D
    J Am Acad Child Adolesc Psychiatry; 2015 Feb; 54(2):126-137.e1. PubMed ID: 25617253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase-2 Pilot Study of a Therapeutic Combination of Δ
    Bloch MH; Landeros-Weisenberger A; Johnson JA; Leckman JF
    J Neuropsychiatry Clin Neurosci; 2021; 33(4):328-336. PubMed ID: 34340527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study.
    Bruggeman R; van der Linden C; Buitelaar JK; Gericke GS; Hawkridge SM; Temlett JA
    J Clin Psychiatry; 2001 Jan; 62(1):50-6. PubMed ID: 11235929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome--a pilot study.
    Stephens RJ; Bassel C; Sandor P
    J Child Adolesc Psychopharmacol; 2004; 14(2):255-66. PubMed ID: 15319022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome.
    Kurlan R; Crespi G; Coffey B; Mueller-Vahl K; Koval S; Wunderlich G;
    Mov Disord; 2012 May; 27(6):775-8. PubMed ID: 22407510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.